NDC 65219-371

STIMUFEND

Pegflilgrastim-fpgk

STIMUFEND is a Subcutaneous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Fresenius Kabi Usa, Llc. The primary component is Pegfilgrastim.

• Product ID: 65219-371_e7a3b529-fd96-4327-9611-93c3611eb6aa
• NDC: 65219-371
• Product Type: Human Prescription Drug
• Proprietary Name: STIMUFEND
• Generic Name: Pegflilgrastim-fpgk
• Dosage Form: Injection, Solution
• Route of Administration: SUBCUTANEOUS
• Marketing Start Date: 2022-10-06
• Marketing Category: BLA /
• Application Number: BLA761173
• Labeler Name: Fresenius Kabi USA, LLC
• Substance Name: PEGFILGRASTIM
• Active Ingredient Strength: 6 mg/.6mL
• Pharm Classes: Granulocyte Colony-Stimulating Factor [CS], Granulocyte-Macrophage Colony-Stimulating Factor [CS], Increased Myeloid Cell Production [PE], Leukocyte Growth Factor [EPC]
• NDC Exclude Flag: N
• Listing Certified Through: 2023-12-31

Packaging

NDC 65219-371-10

1 BLISTER PACK in 1 CARTON (65219-371-10) > 1 SYRINGE in 1 BLISTER PACK > .6 mL in 1 SYRINGE

• Marketing Start Date: 2022-10-06
• NDC Exclude Flag: N
• Sample Package?: N

Drug Details